Welcome to Our Blog

Subscribe below to get free access to our latest newsletter and watch our product video

Semalytix’ and Boehringer Ingelheim’s innovative social media study on the parental experience around Crohn’s disease wins EphMRA award

A patient preference study of Crohn’s disease treatments, carried out by Semalytix and partner Boehringer Ingelheim, has won a...

( read )

Tags: Semalytix, Pharma, PatientListening,

How Multilingual Text Analytics leverages Patient Centricity in Health Care

At Semalytix, we are committed to supporting pharmaceutical companies in their endeavors concerning patient-focused drug...

( read )

Tags: AI, Healthcare, Pharma,

Building Trust by Listening: A Priority During Lockdown

The behavior and responsiveness of all companies and brands during the coronavirus crisis will have a big impact on how they...

( read )

Tags: "patient listening", Healthcare, COVID19,

Leveraging Patient-Focused Drug Development by Social Media Patient Listening Studies
Philipp Cimiano (Chief Technology Officer)
Matthias Hartung (Chief Research Officer)
Jens Höwelkröger (Product Manager)

( read )

Tags: Semalytix, AI, Healthcare,

Are you listening? Patients will tell you what a good drug looks like.

Patients’ voices are no longer a nice-to-have in drug development. They are a critical determinant of commercial success. As...

( read )

Tags: Semalytix, "patient listening", "Health"

What the pharmaceutical industry can learn from online conversations about healthcare

People talk about everything online – including health. The pharmaceutical industry can pay attention. The start-up Semalytix...

( read )
White Paper: AI-Powered Real-World Evidence Generation

Improving Pharma’s Ability to Focus on the Needs of Key Stakeholders

Executive Summary

( read )

Tags: Paper, Semalytix, AI

How machines can measure the real impact of new therapies

By Melanie Senior, Analyst and Specialist, Writer in Pharma, Life Sciences

( read )

Tags: Semalytix

Semalytix’ Knowledge Graph featured at the Neo4J Meeting „GraphTalk: Health & Life Sciences“ in Basel

The knowledge graph developed by Semalytix comprises of millions of pharma-relevant entities modeling key knowledge about...

( read )

Tags: Semalytix

Pharma Pricing & Market Access (PPMA) Conference Learnings

Looking at Market Access for the pharmaceutical industry through the eyes of somebody involved in machine learning and...

( read )

Tags: Semalytix